NCT01355471

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 293 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once daily is more efficacious than vehicle and provides an acceptable safety profile in the treatment of facial erythema associated with rosacea.

Conditions

• Rosacea

Interventions

Type	Name	Description
DRUG	CD07805/47 Gel	applied topically once daily
DRUG	Placebo	applied topically once daily

Timeline

• Start date: 2011-05-01
• Primary completion: 2011-11-01
• Completion: 2012-01-01
• First posted: 2011-05-18
• Last updated: 2021-02-18
• Results posted: 2013-11-21

Locations

15 sites across 2 countries: United States, Canada